期刊文献+

肺炎支原体CARDS毒素致病机制和应用研究进展 被引量:3

Research progress on pathogenic mechanism and application of Mycoplasma pneumoniae community acquired respiratory distress syndrome toxin
原文传递
导出
摘要 社区获得性呼吸窘迫综合征(CARDS)毒素是近年来发现的肺炎支原体唯一的毒力因子,在肺炎支原体的致病过程中发挥重要作用。及时掌握CARDS毒素的作用机制,有助于深入理解肺炎支原体感染的致病特点,为治疗和预后评估提供参考。检测临床样本中是否存在CARDS毒素并监测其浓度变化,为临床肺炎支原体感染的诊断和治疗评估提供了新的方向。本文就肺炎支原体CARDS毒素的发现、致病机制、检测方法及临床价值作一简要综述。 Community acquired respiratory distress syndrome(CARDS)toxin is the only virulence factor of Mycoplasma pneumoniae found in recent years,which plays an important role in the pathogenic process of Mycoplasma pneumoniae.Timely understanding the mechanism of CARDS toxin is helpful to elucidate the pathophysiology of Mycoplasma pneumoniae infection and provide reference for treatment and prognosis evaluation.Detection of CARDS toxin in clinical samples and monitoring of its concentration changes provide a new direction for the diagnosis and treatment evaluation of Mycoplasma pneumoniae infection.This article briefly reviews the discovery,pathogenic mechanism,detection methods and clinical value of Mycoplasma pneumoniae CARDS toxin.
作者 方云 柏长青 牛文凯 苑鑫 Fang Yun;Bai Changqing;Niu Wenkai;Yuan Xin(Department of Respiratory and Critical Care Diseases,Senior Department of Infectious Diseases,the Fifth Medical Center of PLA General Hospital,Beijing 100071,China)
出处 《国际呼吸杂志》 2021年第18期1424-1427,共4页 International Journal of Respiration
基金 国家自然科学基金(81400009) 首都临床特色应用研究(Z141107002514182) 青年培育拔尖项目(20QNPY115)。
关键词 社区获得性呼吸窘迫综合征毒素 支原体 肺炎 致病机制 研究进展 Community acquired respiratory distress syndrome toxin Mycoplasma pneumoniae Pathogenic mechanism Research progress
  • 相关文献

参考文献10

二级参考文献84

  • 1林通,郭娜,杨泽庆,姚子昂.自噬在自身炎症性疾病中的研究进展[J].现代免疫学,2020,40(2):162-166. 被引量:3
  • 2刘引,王子才,方洁,徐昀.肺炎支原体IgM测定的临床意义[J].临床儿科杂志,2005,23(8):560-561. 被引量:30
  • 3宋焕景,王桂珍,董占双,刘忠顺,吉兆华,周吉海.肺炎支原体P1重组蛋白的提取纯化及应用研究[J].微生物学杂志,2007,27(3):107-110. 被引量:5
  • 4赵芝娜,王桂珍,董占双,等.肺炎支原体Pl黏附蛋白基因的克隆与表达[J].中国人兽共患病杂志,2005,21(6):470-478. 被引量:1
  • 5Polverino E, Torres Marti A. Community-acquired pneumonia. Minerva anestesiologica 2011 ; 77:196-211. 被引量:1
  • 6Apisarnthanarak A, Mundy LM. Etiology of community-acquired pneumonia. Clin Chest Med 2005; 26: 47-55. 被引量:1
  • 7Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67: 71-79. 被引量:1
  • 8Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20: 820-837. 被引量:1
  • 9Monte SV, Paolini NM, Slazak EM, Schentag J J, Paladino JA. Costs of treating lower respiratory tract infections. Am J Manag Care 2008; 14: 190-196. 被引量:1
  • 10Carbonara S, Monno L, Longo B, Angarano G. Community-acquired pneumonia. Curr Opin Pulm Med 2009; 15: 261-273. 被引量:1

共引文献241

同被引文献24

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部